Upgrade to SI Premium - Free Trial

ANI Pharmaceuticals gets FDA approval for generic everolimus suspension

September 23, 2026 6:55 AM
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced it received final approval from the U.S. Food and Drug Administration for its Abbreviated ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA